Skip to content

Public FDA record

Z-0454-2022: iontoPATCH On-the-Go Patch Therapy, Transdermal Iontophoretic Drug Delivery System, Extra Strength, 8-HO

Recall record Z-0454-2022 for Tapemark Company. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0454-2022
Company in FDA record
Tapemark Company
FDA record creation date
Jan 5, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

The dosage information on the pouch is incorrect; the primary carton label is correct.

Source facts

Action
Tapemark issued an email on 11/10/2021 to their consignees explaining the pouch dosage is labeled incorrectly as 80 mA/min but the box is labeled correctly with a dosage of 120mA/min. In addition, the patches within the pouch are the 120mA/min patches for the the correct wear time. The email requests the consignee place the affected product on hold and not fill any orders with it, and Tapemark will provide another letter to pass onto their downstream customers who received the affected product to alert them of the mislabeling information. The email goes on to say no corrective action is necessary for their customers since the patch performs as described on the labeled box. On 11/30/2021, Tapemark issued another email to their consignees containing a recall letter dated 30NOV2021 and a subdistributor notification and acknowledgment dated 29NOV2021. The email says Tapemark is recalling the affected lot numbers due to the pouch being labeled incorrectly. Tapemark's consignee is to notify their customers by forwarding the email containing the subdistributor notification and acknowledgment form and to cease distribution. Tapemark's consignee is to let the them, Tapemark, know the quantity sent to the customer and the quantity they have remaining by 12/3/2021. The consignee's customer is to return their remaining inventory to Tapemark. Acknowledgment forms were enclosed with both the consignee letter and the subdistributor letter.
Initiated
2021-11-10
Root cause
Labeling Change Control
Terminated
2023-02-01
Distribution
US Nationwide distribution in the states of CA, FL, IL, MO, NY, OH, and TN.
Recall number
Z-0454-2022
Recall status
Terminated
CDRH record ID
190657
FDA record created
2022-01-05
Recall event number
89161

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗